Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
228 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (2)
  • Currently Recruiting (1)
  • (-) Closed (1)

Medical Condition

  • Show all (88)
  • Autoimmune Disorders (4)
  • Blood Disorders (33)
  • Cancer (1)
  • Endocrine & Metabolic Disease (1)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (3)
  • Heart Disease (1)
  • Kidney Disease (1)
  • Neurological Disorders (36)
  • Obstetrics & Gynecology (1)
  • (-) Pediatrics (1)
  • Psychiatric Disorders (5)
Displaying 1 - 1 of 1

ICON3: A Phase 3 Study of Eltrombopag vs. Standard Therapy for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Condition: Pediatrics
Investigator: Cindy Neunert, MD
Status: Closed
The purpose of this study is to investigate the safety and effectiveness of eltrombopag (investigational drug) in treating children and adolescents with newly-diagnosed immune thrombocytopenia (ITP), which is a rare blood disorder.
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science